Exclusivity Information
Simplicef holds 1 exclusivity out of which 1 has expired. Details of Simplicef's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Jul 22, 2009 |
Simplicef Petitions
Details of Simplicef's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Ray Law Firm, PLLC | Approved | 16 Feb, 2021 | The proposed changes are the addition of a 50 mg tablet strength and the removal of scoring from the 100 and 200 mg tablet strengths. The RLNAD is approved as scored tablets in 100 mg and 200 mg tablet strengths. |
| Felix Pharmaceuticals Pvt. Ltd. | Approved | 10 Jan, 2017 | The proposed change is in dosage form. The RLNAD is approved as a compressed, film-coated tablet. The proposed change is for a soft chewable tablet. |
| Piedmont Animal Health | Approved | 09 Dec, 2013 | The generic product will differ in dosage form. The RLNAD is approved as a film-coated tablet and the proposed generic product is a formed soft chewable tablet. |
About Simplicef
Simplicef is a drug
owned by ZOETIS INC.
Simplicef uses
Cefpodoxime Proxetil as the active
ingredient.
Active Ingredient:
Simplicef uses
Cefpodoxime Proxetil as the active ingredient.
Check out other Drugs and Companies using
Cefpodoxime Proxetil ingredient.